Ensitrelvir fumarate is an orally active antiviral compound that inhibits the SARS-CoV-2 3CL protease, blocking viral replication. As a small-molecule therapeutic, it is used in the development of COVID-19 treatments and related antiviral research.
Inventor/Owner/Manufacturer/Supplier
Stage of Development/Technology Rediness Level (TRL)
Human health and environmental benefits
Ensitrelvir fumarate contributes to public health by supporting the development of more effective antiviral therapies with improved safety and accessibility. Its targeted mechanism reduces viral load efficiently, potentially shortening illness duration and lowering healthcare burden, while enabling more sustainable manufacturing routes for next-generation antiviral drugs.
Category
Keywords
Link to Technology Webpage
Country(ies) Where Commercially Available
United States